These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence of Rh anti-E and anti-c production among Japanese after blood transfusion. Komatsu F Bull Tokyo Med Dent Univ; 1988 Sep; 35(3):75-9. PubMed ID: 3148374 [TBL] [Abstract][Full Text] [Related]
3. [Circulating plaque forming cells in Rh-sensibilisation (author's transl]. Baenkler HW; Schrenk K Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):419-25. PubMed ID: 4282924 [No Abstract] [Full Text] [Related]
4. [Analysis of irregular antibodies in the department of transfusion medicine 1984-1988]. Wittkopf D; Grundmann A; Sibrowski W; von Eisenhart-Rothe V; Kühnl P Beitr Infusionsther; 1990; 26():415-9. PubMed ID: 1703889 [TBL] [Abstract][Full Text] [Related]
5. [Rhesus serological status of hemophilia patients]. Mikhaĭlova AA; Klimov AA Probl Gematol Pereliv Krovi; 1982 Apr; 27(4):35-7. PubMed ID: 6808499 [No Abstract] [Full Text] [Related]
6. [Strategies for prevention of adverse transfusion effects. Immediate and delayed transfusion effects: laboratory reference for transfusion reactions]. Kiyokawa H Rinsho Byori; 1991 Mar; Suppl 88():128-37. PubMed ID: 1856964 [No Abstract] [Full Text] [Related]
7. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel? Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895 [No Abstract] [Full Text] [Related]
8. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Cox JV; Steane E; Cunningham G; Frenkel EP Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of 2-years experiences with crossmatching in the Institute of Hematology]. Frankowska K; Górska B; Kacperska E; Maczyńska-Rusiniak B; Seyfried H Pol Tyg Lek; 1969 Jun; 24(22):838-41. PubMed ID: 4979419 [No Abstract] [Full Text] [Related]
14. [Irregular erythrocytic antibodies as an obstacle to transfusion]. Uhlig R; Endert G; Lammel G Z Arztl Fortbild (Jena); 1984; 78(20):849-52. PubMed ID: 6523909 [No Abstract] [Full Text] [Related]
15. Advances in solid phase red cell adherence methods and transfusion serology. Sinor LT Beitr Infusionsther; 1990; 26():345-7. PubMed ID: 1703870 [No Abstract] [Full Text] [Related]
16. [The gel centrifugation test in serologic compatibility testing]. Hitzler W; Bauernfeind U; Schömig-Brekner J; Mathias D Beitr Infusionsther; 1990; 26():358-61. PubMed ID: 1703871 [TBL] [Abstract][Full Text] [Related]
17. Clinically significant and insignificant antibodies in blood transfusion. Morel PA; Garratty G; Perkins HA Am J Med Technol; 1978 Feb; 44(2):122-9. PubMed ID: 414622 [No Abstract] [Full Text] [Related]
18. [Analysis of irregular antibodies at the department of transfusion medicine of the Hamburg-Eppendorf University Hospital 1984-1988]. Wittkopf D; Grundmann A; Sibrowski W; von Eisenhart-Rothe B; Kühnl P Infusionstherapie; 1990 Oct; 17(5):280-2. PubMed ID: 2127047 [TBL] [Abstract][Full Text] [Related]
19. Prenatal screening in the serodiagnosis of blood group sensitization. Wieczorek P; Wegrzecki R Acta Eur Fertil; 1973 Jun; 4(2):85-7. PubMed ID: 4206119 [No Abstract] [Full Text] [Related]
20. [Possibility of erroneous interpretation of Rh-reference of blood in patients with autoerythrocytic aggression]. Mikhaĭlova AA Probl Gematol Pereliv Krovi; 1973 Jun; 18(6):60-2. PubMed ID: 4202025 [No Abstract] [Full Text] [Related] [Next] [New Search]